Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
Login Archives Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
    ×
  • Subscribe
Enter stock ticker or keyword
×
Join 100,000+ Like-Minded Investors Today
Twitter
Tags: stocks
Stocks: INSY

One of the Best Biotech Stocks of 2017 Could See 130% Gains This Year

By Money Morning News Team, Money Morning • August 1, 2017

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

Best Biotech StocksBack in May, Money Morning Executive Editor Bill Patalon recommended one of the best biotech stocks of 2017. Readers who followed Patalon's advice to buy this stock ahead of an FDA decision date of May 24 saw gains as high as 26% in just two weeks.

Gains this large make it easy to think you missed the boat. But it isn't too late to buy Patalon's biotech stock pick. In fact, one Wall Street analyst thinks this stock could gain as much as 130% in the next 12 months.

And the company's cancer drugs are a big reason for the expected gains...

Why This Is One of the Best Biotech Stocks to Buy in 2017

The company's main drug is currently the only treatment on the market for breakthrough cancer pain (BTCP). The treatment delivers a powerful drug in liquid form so it can be absorbed under the tongue.

BREAKING: New Legislation Could Turn Tiny Pot Stocks into Millions. Click Here...

Sales of the drug to the company's four largest wholesalers were $22 million in Q1 this year. An additional $11 million worth of the drug went to specialty pharmacies during the same quarter.

This isn't the only good news for the biotech company.

On May 24, the company received final approval from the FDA for a new drug. The drug, which was made available yesterday (Monday), is a cannabis-derived treatment for chemotherapy-induced nausea and vomiting.

This new drug will have a large market. The National Cancer Institute reports that there were nearly 15 million people with cancer in the United States alone in 2014. Of those patients, 80% reported dealing with nausea and vomiting.

The new drug also puts the company at the convergence of two very powerful trends in the biotech industry that will propel the stock higher...

Here Are 10 “One-Click” Ways to Earn 10% or Better on Your Money Every Quarter

Appreciation is great, but it’s possible to get even more out of the shares you own. A lot more: you can easily beat inflation and collect regular income to spare. There are no complicated trades to put on, no high-level options clearances necessary. In fact, you can do this with a couple of mouse clicks – passive income redefined. Click here for the report…

Claim My Free Report

Subscribe
Login
Notify of
guest

guest

1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Dragontitus
Dragontitus
6 years ago

Or, even better, invest in marijuana stock and let big pharma wither away and die.. Then you could make money in addition to promoting a healthy, effective solution to cancer AND save the lives of thousands of opioid addicts. Not to mention how beneficial this natural herb, that destroys carbon while producing oxygen, would prove to be for global warming.

0
Reply


Latest News

September 18, 2023 • By Garrett Baldwin

Dogs That Are Fluent in Spanish for $200, Alex.

September 18, 2023 • By Shah Gilani

earnings
This Income Play Is a Perfect Hedge in a Sluggish Market

September 15, 2023 • By Shah Gilani

We're Headed for a Second Banking Crisis - Here's What to Do
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Penny Hawk Midday Momentum
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Quantum Data Profits Flashpoint Trader Darknet Alpha Accelerators Brutus Alerts Resource Traders Alliance L.A.U.N.C.H. Investor Rob Roy Trader Long-Term Equity Profits

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information

wpDiscuz